3D model is for representation purpose only.
.
.
XASXQSL | Doxorubicin |
Identification | |
---|---|
ConjuPepDB ID | cpd01498 |
Smiles | |
Molecular weight | 1395.6 |
Molecular formula | C65H89N9O25 |
Chemical name | Peptide information |
Sequence (one letter) | XASXQSL |
Length | 7 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 207395-85-5 |
Other information | |
---|---|
Application | Anticancer therapy, prostate targeting |
Additional function | Clinical trials, safety and PK |
Pharmacological class | anticancer |
Conjugate type | amide |
Linker | no |
Small molecule | Doxorubicin |
Small molecule CAS | 23214-92-8 |
Calculated properties | |
---|---|
LogP | -3.28054 |
Rotatable bonds | 31 |
H bond donor | 17 |
H bond acceptor | 25 |
Polar surface area (PSA) | 545.14000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer | 2002 | DiPaola, Robert S.; Rinehart, John; Nemunaitis, John; Ebbinghaus, Scott; Rubin, Eric; Capanna, Terry; Ciardella, Marie; Doyle-Lindrud, Susan; Goodwin, Susan; Fontaine, Michelle; Adams, Ned; Williams, Adrienne; Schwartz, Michael; Winchell, Greg; Wickersham, Karen; Deutsch, Paul; Yao, Siu-Long | Journal of Clinical Oncology |